Elderly at risk of hospitalizations from key medications

Promoting safe use of blood thinners and diabetes medications can protect patients

 

Atlanta, GA, USA (November 23, 2011) – Each year, there are nearly 100,000 emergency hospitalizations for adverse drug events in U.S. adults aged 65 years or older, according to a Centers for Disease Control and Prevention study published today in the New England Journal of Medicine . Of the thousands of medications available to patients, a small group of blood thinners and diabetes medications caused two–thirds of the emergency hospitalizations, the report said.

 

“These data suggest that focusing safety initiatives on a few medicines that commonly cause serious, measurable harms can improve care for many older Americans,” said Dan Budnitz, M.D., M.P.H., director of CDC′s Medication Safety Program. “Blood thinners and diabetes medicines often require blood testing and dosing changes, but these are critical medicines for older adults with certain medical conditions. Doctors and patients should continue to use these medications but remember to work together to safely manage them.”

 

The study used data collected between 2007 and 2009 from a nationally representative sample of 58 hospitals participating in CDC′s National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance project. Almost half (48.1 percent) of these hospitalizations occur among adults aged 80 years or older, and two–thirds (65.7 percent) of the hospitalizations were due to overdoses, or to situations in which patients may have taken the prescribed amount of medication but the drug had more than the intended effect on the patient′s body.

 

Four medications, used alone or together, accounted for two–thirds of the emergency hospitalizations:

  • 33 percent, or 33,171 emergency hospitalizations, involved warfarin , a medication used to prevent blood clots.
  • 14 percent involved insulin s. Insulin injections are used to control blood sugar in people who have diabetes.

 

This study identified specific medication safety issues that provide the greatest opportunities for reducing patient harm and health care utilization today. Continued national monitoring of adverse drug events will be important as new medications are approved and become more commonly used.

 

CDC scientists noted medications currently identified by national quality measures as being high–risk or potentially inappropriate for older patients were rarely identified as the cause of emergency hospitalizations (1.2 percent and fewer than 6.6 percent, respectively).

 

“Policies and improvement programs to promote safe use of medications that most commonly cause serious, measureable harms can increase patient safety and reduce unnecessary hospitalizations and costs at the same time,” said Patrick Conway, M.D., M.Sc., chief medical officer of the Centers for Medicare & Medicaid Services and director of CMS′ Office of Clinical Standards and Quality. “We are working across the federal government to address common preventable adverse drug events through medication management, care transition programs , and other initiatives.”

 

One initiative, the Partnership for Patients , includes an effort to decrease the number of preventable rehospitalizations by 20 percent by the end of 2013. Older adults are nearly seven times as likely as younger people to have adverse drug events that require hospitalization. Hospitalizations for adverse drug events have the potential to increase as Americans live longer, have greater numbers of chronic conditions, and take more medications. Decreasing adverse drug events, including those from blood thinners and diabetes medications, is a key area of focus for the Partnership for Patients.

 

For more information about what CDC is doing to protect older adults from adverse drug events, visit www.cdc.gov/medicationsafety

 

CDC works 24/7 saving lives, protecting people from health threats, and saving money through prevention. Whether these threats are global or domestic, chronic or acute, curable or preventable, natural disaster or deliberate attack, CDC is the nation′s health protection agency.

 


 

Centers for Disease Control and Prevention, 23.11.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…